This research output has an Altmetric Attention Score of 229. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2026.
All research outputs
#210,530
of 34,566,154 outputs
Outputs from JAMA Oncology
#336
of 3,971 outputs
Outputs of similar age
#2,778
of 345,304 outputs
Outputs of similar age from JAMA Oncology
#10
of 98 outputs
Altmetric has tracked 34,566,154 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,971 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 83.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,304 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.
